Received Oct 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | 3052741 | IM |
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
full body intense hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (full body intense hives) in a 26-year-old female patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (batch no. 3052741) for COVID-19 prophylaxis. Co-suspect product included Pre-filled Syringe injection (batch no. 3052741) for COVID-19 prophylaxis and non-company product included Influenza vaccine (Flu) for an unknown indication. Psoriasis. Concurrent medical conditions included Psoriasis. On 14-Oct-2025, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) .5 milliliter and dose of Influenza vaccine (Flu) (unknown route) 1 dosage form. On an unknown date, the patient started Pre-filled Syringe (unknown route) at an unspecified dose. On 17-Oct-2025, the patient experienced URTICARIA (full body intense hives). The patient was treated with Prednisone for Hives, at a dose of 20 milligram once a day; Diphenhydramine hydrochloride (Benadryl) for Hives, at an unspecified dose and frequency and Cetirizine hydrochloride (Zyrtec) for Hives, at an unspecified dose and frequency. At the time of the report, URTICARIA (full body intense hives) had not resolved. No concomitant medications were provided. The patient got full body intense hives on 17-Oct-2025, (Friday night) that still had not gone away, even after urgent care visit. It was unknown if the patient experienced any additional symptoms/events. The patient did not have any additional medical history, concomitant disease or risk factor. There were no lab data/results available.
Psoriasis
Comments: Psoriasis